These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2903793)

  • 1. Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells.
    Hamada H; Okochi E; Watanabe M; Oh-hara T; Sugimoto Y; Kawabata H; Tsuruo T
    Cancer Res; 1988 Dec; 48(24 Pt 1):7082-7. PubMed ID: 2903793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells.
    Meyers MB; Rittmann-Grauer L; O'Brien JP; Safa AR
    Cancer Res; 1989 Jun; 49(12):3209-14. PubMed ID: 2566379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
    Yusa K; Tsuruo T
    Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies.
    Hamada H; Okochi E; Oh-hara T; Tsuruo T
    Cancer Res; 1988 Jun; 48(11):3173-8. PubMed ID: 3365700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning and characterization of the complementary DNA for the M(r) 85,000 protein overexpressed in adriamycin-resistant human tumor cells.
    Sugimoto Y; Hamada H; Tsukahara S; Noguchi K; Yamaguchi K; Sato M; Tsuruo T
    Cancer Res; 1993 Jun; 53(11):2538-43. PubMed ID: 8495417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-resistance of human multidrug-resistant cells to mitomycin C.
    Yusa K; Sato W; Yamazaki A; Tsukahara S; Tsuruo T
    Anticancer Res; 1991; 11(3):1301-4. PubMed ID: 1909515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
    Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
    Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones.
    Tsuruo T; Iida-Saito H; Kawabata H; Oh-hara T; Hamada H; Utakoji T
    Jpn J Cancer Res; 1986 Jul; 77(7):682-92. PubMed ID: 3091555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
    Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK506 reverses adriamycin resistance in a multidrug-resistant human leukemia cell line.
    Natazuka T
    Kobe J Med Sci; 1992 Dec; 38(6):347-63. PubMed ID: 1284834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
    Hill AB; Beck WT; Trent JM
    Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a P-glycoprotein-related protein (mini-P-glycoprotein) which is overexpressed in multidrug resistant cells.
    Kawai K; Kusano I; Ido M; Sakurai M; Shiraishi T; Yatani R
    Biochem Biophys Res Commun; 1994 Jan; 198(2):804-10. PubMed ID: 7905266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-mediated transfer and cloning of a human multidrug-resistant gene of adriamycin-resistant myelogenous leukemia K562.
    Sugimoto Y; Tsuruo T
    Cancer Res; 1987 May; 47(10):2620-5. PubMed ID: 3032411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement.
    Naito M; Tsuruo T
    Cancer Res; 1989 Mar; 49(6):1452-5. PubMed ID: 2924298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological characterization of multidrug-resistant human colon carcinoma sublines induced/selected by two methods.
    Yang LY; Trujillo JM
    Cancer Res; 1990 Jun; 50(11):3218-25. PubMed ID: 2334917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
    Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
    Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
    Tsuruo T
    Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of adriamycin resistance by fusion of Mr 170,000 P-glycoprotein to the plasma membrane of sensitive cells.
    Belli JA; Zhang Y; Fritz P
    Cancer Res; 1990 Apr; 50(7):2191-7. PubMed ID: 1969329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.